ABVC BIOPHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fremont, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ABVC BIOPHARMA, INC. has filed 792 SEC EDGAR filings since 28 Jun 2002

SEC filing history

Showing 101-125 of 581 matching filings.

Per page
25
Current page
5
8-K File 001-40700

CURRENT REPORT

Filing date
24 May 2024
Reporting date
24 May 2024
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
23 May 2024
Reporting date
23 May 2024
Next action
Verify source filing
424B4 File 333-255112

PROSPECTUS SUPPLEMENT

Filing date
23 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-255112

PROSPECTUS

Filing date
22 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-276500

PROSPECTUS SUPPLEMENT

Filing date
22 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-40700

FORM 8-K/A

Filing date
17 May 2024
Reporting date
08 Feb 2024
Next action
Verify source filing
10-Q File 001-40700

QUARTERLY REPORT

Filing date
17 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
NT 10-Q File 001-40700

NOTIFICATION OF LATE FILING

Filing date
15 May 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
15 May 2024
Reporting date
15 May 2024
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
09 May 2024
Reporting date
09 May 2024
Next action
Verify source filing
EFFECT File 333-255112

EFFECT filing

Filing date
30 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40700

PRELIMINARY PROXY STATEMENT

Filing date
26 Apr 2024
Reporting date
26 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-255112

POST-EFFECTIVE AMENDMENT NO. 3 TO FORM S-1

Filing date
25 Apr 2024
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
17 Apr 2024
Reporting date
17 Apr 2024
Next action
Verify source filing
424B4 File 333-276500

PROSPECTUS

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-276500

EFFECT filing

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
26 Mar 2024
Reporting date
26 Mar 2024
Next action
Verify source filing
DEFA14A File 001-40700

DEFINITIVE ADDITIONAL MATERIALS

Filing date
25 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-276500

AMENDMENT NO. 3 TO FORM S-1

Filing date
22 Mar 2024
Reporting date
Not listed
Next action
Verify source filing
10-K/A File 001-40700

AMENDMENT NO. 1 TO FORM 10-K

Filing date
15 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
DEFA14A File 001-40700

DEFINITIVE ADDITIONAL MATERIALS

Filing date
14 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40700

CURRENT REPORT

Filing date
14 Mar 2024
Reporting date
14 Mar 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .